Gene Symbol | Pearson Correlation Coefficient |
---|---|
IGSF3 | 0.851 |
PCDH8 | 0.847 |
FAM163A | 0.842 |
LRRTM4 | 0.842 |
RHOV | 0.838 |
LINGO2 | 0.838 |
ASB2 | 0.834 |
NDST3 | 0.832 |
KCNN2 | 0.831 |
RTP1 | 0.83 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
HEY2 | -0.59 |
YES1 | -0.571 |
TGFB3 | -0.553 |
RAI14 | -0.546 |
REST | -0.538 |
FAM114A1 | -0.536 |
SEPT10 | -0.53 |
ROM1 | -0.525 |
CPM | -0.524 |
SNHG18 | -0.521 |
ID | Drug Name | Drug Type | CAS Num | Status | Role |
---|---|---|---|---|---|
DB05532 | BMS-488043 | Small Molecule | 452296-83-2 | Investigational | Target |
DB05793 | PRO-542 | BiotechDrug | - | Investigational | Target |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C547126 | AZM551248 | AZM551248 results in decreased expression of FFAR4 mRNA | 22323515 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of FFAR4 mRNA | 19770486 |
C006780 | bisphenol A | bisphenol A results in decreased expression of FFAR4 mRNA | 25181051 |
C006780 | bisphenol A | bisphenol A results in increased methylation of FFAR4 gene | 28505145 |
D002737 | Chloroprene | Chloroprene results in increased expression of FFAR4 mRNA | 23125180 |
D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FFAR4 mRNA | 20938992 |
D003999 | Dichloroacetic Acid | Dichloroacetic Acid results in increased expression of FFAR4 mRNA | 28962523 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of FFAR4 mRNA | 18042831 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of FFAR4 mRNA | 25016146 |
D005395 | Fish Oils | Fish Oils inhibits the reaction [Ozone results in increased expression of FFAR4 mRNA] | 29329427 |
D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FFAR4 mRNA | 20938992 |
C039281 | furan | furan results in increased expression of FFAR4 mRNA | 27387713 |
D019833 | Genistein | Genistein results in increased methylation of FFAR4 gene | 28505145 |
D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FFAR4 mRNA | 20938992 |
C523799 | MRK 003 | FFAR4 results in decreased susceptibility to MRK 003 | 19903844 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of FFAR4 mRNA" | 25620056 |
D010126 | Ozone | Fish Oils inhibits the reaction [Ozone results in increased expression of FFAR4 mRNA] | 29329427 |
D010126 | Ozone | Ozone results in increased expression of FFAR4 mRNA | 29329427 |
D000073878 | Palm Oil | Palm Oil results in decreased expression of FFAR4 mRNA | 18042831 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of FFAR4 mRNA | 18301758 |
D011441 | Propylthiouracil | Propylthiouracil results in increased expression of FFAR4 mRNA | 24780913 |
D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of FFAR4 mRNA | 25895662 |
D053260 | Soot | Soot results in decreased expression of FFAR4 mRNA | 26551751 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of FFAR4 mRNA | 19770486 |
C009495 | titanium dioxide | titanium dioxide results in decreased expression of FFAR4 mRNA | 23557971 |
C015559 | trimellitic anhydride | trimellitic anhydride results in decreased expression of FFAR4 mRNA | 19042947 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004930 | G-protein coupled receptor activity | - | IBA | 21873635 |
GO:0005504 | fatty acid binding | - | IBA | 21873635 |
GO:0005504 | fatty acid binding | - | ISS | - |
GO:0008527 | taste receptor activity | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0007166 | cell surface receptor signaling pathway | - | IBA | 21873635 |
GO:0007186 | G-protein coupled receptor signaling pathway | - | IBA | 21873635 |
GO:0007186 | G-protein coupled receptor signaling pathway | - | TAS | - |
GO:0010827 | regulation of glucose transmembrane transport | - | ISS | - |
GO:0043066 | negative regulation of apoptotic process | - | ISS | - |
GO:0045444 | fat cell differentiation | - | IEA | - |
GO:0046879 | hormone secretion | - | IBA | 21873635 |
GO:0050710 | negative regulation of cytokine secretion | - | ISS | - |
GO:0050728 | negative regulation of inflammatory response | - | ISS | - |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | - | ISS | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005886 | plasma membrane | - | ISS | - |
GO:0005886 | plasma membrane | - | TAS | - |
GO:0005887 | integral component of plasma membrane | - | IBA | 21873635 |
GO:0030139 | endocytic vesicle | - | IEA | - |
KEGG ID | KEGG Term |
---|
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-162582 | Signal Transduction | IEA |
R-HSA-2980736 | Peptide hormone metabolism | TAS |
R-HSA-372790 | Signaling by GPCR | TAS |
R-HSA-372790 | Signaling by GPCR | IEA |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | IEA |
R-HSA-381771 | Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | TAS |
R-HSA-388396 | GPCR downstream signalling | TAS |
R-HSA-392499 | Metabolism of proteins | TAS |
R-HSA-400508 | Incretin synthesis, secretion, and inactivation | TAS |
R-HSA-416476 | G alpha (q) signalling events | TAS |
R-HSA-444209 | Free fatty acid receptors | IEA |
R-HSA-500792 | GPCR ligand binding | IEA |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
25644374 | Informed genome-wide association analysis with family history as a secondary phenotype identifies novel loci of lung cancer. (2015 Mar) | Poirier JG | Genet Epidemiol |